Name

Alternate Names

GM2-KLH/QS-21
GM2/GD2 gangliosides-KLH vaccine
VMO (vaccinia melanoma oncolysate vaccine)

Abbreviations

None

Category

Biologic therapy (BRM, immunotherapy)

Subcategory

Immunotherapy active

NSC Number

725532
713762

Primary Site

Colorectal
gastric
lung cancer
lymphoma
neuroblastoma
sarcoma

Histology

None

Remarks

Phase I (colorectal, gastric, lung) Phase I/II (SCLC, lymphoma, neuroblastoma, sarcoma) Vaccine. Progenics Pharmaceuticals.

Coding

This drug should be coded
Glossary